BRIEF-Neuroderm initiates patient enrollment in a phase III trial of ND0612l for trea
 

BRIEF-Neuroderm initiates patient enrollment in a phase III trial of ND0612l for treatment of Parkinson?s disease
* Neuroderm initiates patient enrollment in a phase iiitrial of nd0612l for treatment of parkinson's diseasehttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...gU:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...gU:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/fWGXfk5Wn8I